{
    "clinical_study": {
        "@rank": "6394", 
        "arm_group": [
            {
                "arm_group_label": "Usual Care", 
                "arm_group_type": "Other", 
                "description": "Usual hospital rehabilitative services"
            }, 
            {
                "arm_group_label": "Early ICU Rehabilitation Strategy", 
                "arm_group_type": "Experimental", 
                "description": "Early ICU physical therapy will be applied in this arm"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized, controlled, pilot study of two separate Cohorts of patients from the\n      intensive care unit. Cohort I will enroll 50 patients and randomize to receive one physical\n      therapy session per day or receive usual ICU care. Cohort II, will enroll an additional 50\n      patients and randomize to receive either two physical therapy sessions per day or usual\n      care. Outcome will be length of hospital stay measured in days.  Secondary outcomes will be\n      mortality, ventilator days, ICU days, and for Cohort II, grip strength, dynamometer strength\n      assessments and the short physical performance battery (SPPB).  Study subjects will have\n      blood for cytokine analysis through their first week of study."
        }, 
        "brief_title": "Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure", 
        "completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "condition": "Acute Respiratory Failure", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Adult", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        \u2022 Mechanically ventilated via an endotracheal tube or mask\n\n        Exclusion Criteria:\n\n          -  Inability to walk without assistance prior to acute ICU illness (use of a cane or\n             walkers not exclusions)\n\n          -  Cognitive impairment prior to acute ICU illness (non-verbal)\n\n          -  Preadmit immunocompromised (>prednisone 20 mg/d for 2 wks)\n\n          -  Acute stroke\n\n          -  Body mass index (BMI) >45\n\n          -  Neuromuscular disease that could impair weaning (myasthenia gravis, ALS,\n             Guillain-Barre)\n\n          -  Hip fracture, unstable cervical spine or pathological fracture\n\n          -  Mech vent >48 hours prior to transfer from an outside facility\n\n          -  Current hospitalization or transferring hospital stay >72 hours\n\n          -  CPR on admission, DNR on admission\n\n          -  Hospitalization within 30 days prior to admission\n\n          -  Cancer therapy within last 6 months\n\n          -  Re-admission to ICU within current hospitalization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707303", 
            "org_study_id": "IRB00000240"
        }, 
        "intervention": [
            {
                "arm_group_label": "Early ICU Rehabilitation Strategy", 
                "description": "Physical therapy - standard; Physical therapy, progressive resistance training for 2nd physical therapy session in Cohort II", 
                "intervention_name": "Early ICU rehabilitation strategies", 
                "intervention_type": "Other", 
                "other_name": "Cohort I will receive one physical therapy session per day; Cohort II will receive 2 physical therapy sessions per day."
            }, 
            {
                "arm_group_label": "Usual Care", 
                "description": "All typically applied hospital rehabilitative services applied in the usual fashion", 
                "intervention_name": "Usual Care", 
                "intervention_type": "Other", 
                "other_name": "Usual Hospital Rehabilitative Services"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "ICU", 
            "Critical Care", 
            "Intensive Care", 
            "Critical Illness", 
            "Acute Respiratory Failure", 
            "Mechanical Ventilation", 
            "Physical Therapy", 
            "Strength", 
            "Functional Status", 
            "Short Physical Performance Battery"
        ], 
        "lastchanged_date": "October 12, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Winston Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27157"
                }, 
                "name": "Wake Forest School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect Of Acute Inflammatory Mediators On Duration Of Functional Limitations In Patients With Acute Respiratory Failure, A Randomized, Controlled Pilot Study of Early ICU Rehabilitation Strategies", 
        "overall_official": {
            "affiliation": "Wake Forest School of Medicine", 
            "last_name": "Peter E. Morris, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "July 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Hospital stay measured in days.", 
            "measure": "Hospital length of stay, days", 
            "safety_issue": "No", 
            "time_frame": "The participants will be followed for the duration of the hospitalization, an expected average of 3 weeks."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707303"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wake Forest University", 
            "investigator_full_name": "Peter E. Morris", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Wake Forest School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wake Forest School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}